Literature DB >> 16598541

The metabolic syndrome and the heart--a considered opinion.

J G Leichman1, V R Lavis, D Aguilar, C R Wilson, H Taegtmeyer.   

Abstract

The metabolic syndrome (MS) is a multifactorial, heterogeneous group of risk factors for the development of cardiovascular disease. Here we review the evidence in support of the hypothesis that metabolic dysregulation of the body as a whole leads to contractile dysfunction of the heart due to an imbalance of substrate uptake (increased) and substrate oxidation (decreased). The consequences of this imbalance were already recognized 150 years ago by Virchow when he described "fatty atrophy" of the heart as a "true metamorphosis of the heart muscle cell."

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598541     DOI: 10.1007/s00392-006-1119-7

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  68 in total

Review 1.  Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine.

Authors:  Roger H Unger
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

2.  Cytoplasmic regulation of mRNA function: the importance of the 3' untranslated region.

Authors:  R J Jackson
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

3.  Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro.

Authors:  T Doenst; G W Goodwin; A M Cedars; M Wang; S Stepkowski; H Taegtmeyer
Journal:  Metabolism       Date:  2001-09       Impact factor: 8.694

4.  Lipoprotein secretion and triglyceride stores in the heart.

Authors:  J Bjorkegren; M Véniant; S K Kim; S K Withycombe; P A Wood; M K Hellerstein; R A Neese; S G Young
Journal:  J Biol Chem       Date:  2001-07-31       Impact factor: 5.157

5.  Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice.

Authors:  Ronglih Liao; Mohit Jain; Lei Cui; Jessica D'Agostino; Francesco Aiello; Ivan Luptak; Soeun Ngoy; Richard M Mortensen; Rong Tian
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

6.  Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis.

Authors:  D B Ostrander; G C Sparagna; A A Amoscato; J B McMillin; W Dowhan
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

Review 7.  Genetics of energetics: transcriptional responses in cardiac metabolism.

Authors:  H Taegtmeyer
Journal:  Ann Biomed Eng       Date:  2000-08       Impact factor: 3.934

8.  Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction.

Authors:  C Depre; M E Young; J Ying; H S Ahuja; Q Han; N Garza; P J Davies; H Taegtmeyer
Journal:  J Mol Cell Cardiol       Date:  2000-06       Impact factor: 5.000

9.  alpha-adrenergic stimulation mediates glucose uptake through phosphatidylinositol 3-kinase in rat heart.

Authors:  T Doenst; H Taegtmeyer
Journal:  Circ Res       Date:  1999-03-05       Impact factor: 17.367

10.  Glycogen turnover in the isolated working rat heart.

Authors:  G W Goodwin; J R Arteaga; H Taegtmeyer
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

View more
  12 in total

1.  Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

Authors:  Pavan K Battiprolu; Thomas G Gillette; Zhao V Wang; Sergio Lavandero; Joseph A Hill
Journal:  Drug Discov Today Dis Mech       Date:  2010

2.  Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.

Authors:  Young Lee; Eric D Berglund; Xinxin Yu; May-Yun Wang; Matthew R Evans; Philipp E Scherer; William L Holland; Maureen J Charron; Michael G Roth; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

Review 3.  Adaptation and maladaptation of the heart in obesity.

Authors:  Romain Harmancey; Christopher R Wilson; Heinrich Taegtmeyer
Journal:  Hypertension       Date:  2008-06-23       Impact factor: 10.190

Review 4.  Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity.

Authors:  Roger H Unger; Philipp E Scherer
Journal:  Trends Endocrinol Metab       Date:  2010-03-10       Impact factor: 12.015

Review 5.  Biological activities of receptor-interacting protein 140 in adipocytes and metabolic diseases.

Authors:  Ping-Chih Ho; Li-Na Wei
Journal:  Curr Diabetes Rev       Date:  2012-11

6.  Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study.

Authors:  Giovanni De Simone; Richard B Devereux; Marcello Chinali; Mary J Roman; Ana Barac; Julio A Panza; Elisa T Lee; Barbara V Howard
Journal:  J Hypertens       Date:  2011-07       Impact factor: 4.844

7.  Myocardial Fat Accumulation Is Independent of Measures of Insulin Sensitivity.

Authors:  Ranganath Muniyappa; Radwa Noureldin; Ronald Ouwerkerk; Elizabeth Y Liu; Ritu Madan; Brent S Abel; Katherine Mullins; Mary F Walter; Monica C Skarulis; Ahmed M Gharib
Journal:  J Clin Endocrinol Metab       Date:  2015-05-28       Impact factor: 5.958

Review 8.  Definitions and incidence of cardiac syndrome X: review and analysis of clinical data.

Authors:  I A C Vermeltfoort; P G H M Raijmakers; I I Riphagen; D A M Odekerken; A F M Kuijper; A Zwijnenburg; G J J Teule
Journal:  Clin Res Cardiol       Date:  2010-04-21       Impact factor: 5.460

9.  Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome.

Authors:  Omer Yiginer; Fatih Ozcelik; Tugrul Inanc; Mustafa Aparci; Namik Ozmen; Bekir Yilmaz Cingozbay; Ejder Kardesoglu; Selami Suleymanoglu; Goksel Sener; Bekir Sitki Cebeci
Journal:  Clin Res Cardiol       Date:  2007-12-28       Impact factor: 5.460

10.  Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease.

Authors:  Jochen Wöhrle; Nikolaus Marx; Wolfgang Koenig; Vinzenz Hombach; Hans A Kestler; Martin Höher; Thorsten Nusser
Journal:  Clin Res Cardiol       Date:  2008-04-24       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.